aTyr Pharma (ATYR) shares remain in focus on Thursday after controversial American investor Martin Shkreli revealed a short position against the biotherapeutics firm. According to Shkreli, investors ...

First rising to fame as the "pharma bro" who jacked up the price of an AIDS drug by 5,000% overnight and was eventually convicted of securities fraud, Shkreli is in the spotlight this week for taking ...

NEW YORK (Reuters) -Martin Shkreli must face a lawsuit by a digital art collective that owns a one-of-a-kind album by the hip-hop group Wu-Tang Clan, and accused the convicted former pharmaceutical ...

*Martin Shkreli – the man millions now call a douchebag for trying to price-gouge a life-saving AIDS drug, then, buying the only copy of Wu Tang Clan’s new album “Once Upon a Time in Shaolin” for $2 ...

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge. What Happened: On Saturday, in a post on X, ...